Home » Topics » BioWorld Science

BioWorld Science
RSS

New SMARCA2 inhibitors identified at Bayer

July 13, 2020

Phase II study of CS-02 meets primary endpoint

July 13, 2020

Humanwell Healthcare, Hubei Bio-Pharmaceutical patent PDE4 inhibitors

July 13, 2020

Roche synthesizes new imidazopyrazine antibacterials

July 13, 2020

Liver-specific silencing of MCJ reduces steatosis, inflammation and fibrosis in NASH mouse models

July 13, 2020

Astrocytes, endocannabinoids, metabolism cooperate to affect behavior

July 13, 2020

Crosstalk between sex, stress hormones affects immunity

July 13, 2020

Discovery of novel BET protein degraders as oncolytic drug candidates

July 13, 2020

ADAM9 expression correlates with poor survival in TNBC

July 13, 2020

Uppsala University researchers describe new urothelial bladder cancer model

July 10, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.